Login Register Cart 0
Generic placeholder image

Current Topics in Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 1568-0266
ISSN (Online): 1873-4294

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Editorial

Recent Advances in Drug Discovery and Treatment of Neglected Diseases

Author(s): João H. G. Lago and Luiz Felipe Domingues Passero

Volume 22, Issue 19, 2022

Published on: 28 July, 2022

Page: [1593 - 1594] Pages: 2

DOI: 10.2174/156802662219220728162323

« Previous Next »
[1]
L. F. D. Passero, E. dos S. Brunelli, T. Sauini, et al. The Potential of Traditional Knowledge to Develop Effective Medicines for the Treatment of Leishmaniasis. Front Pharmacolvol 12, Jun 2021.
[2]
G.B. Stefano, N. Pilonis, R. Ptacek and , R.M. Kream. Reciprocal Evolution of Opiate Science from Medical and Cultural Perspectives. Med Sci Monit vol. 23, pp. 2890–2896, Jun. 2017
[3]
C.J. Bailey. Metformin: historical overview. Diabetologia vol. 60, no. 9, pp. 1566–1576, Sep. 2017
[4]
P. J. Boratyński, M. Zielińska-Błajet, J. Skarżewski. Cinchona Alkaloids—Derivatives and Applications 2019, pp. 29–145.
[5]
T.J. Schmidt, S.A. Khalid, A.J. Romanha, et al. The potential of secondary metabolites from plants as drugs or leads against protozoan neglected diseases - part II. Curr Med Chem vol. 19, no. 14, pp. 2176–228, 2012.
[6]
J. Adriana Jesus, M.D. Laurenti, M. Lopes Silva, J.H. Ghilardi Lago, L.F. Domingues Passero. Leishmanicidal Activity and Ultrastructural Changes of Maslinic Acid Isolated from Hyptidendron canum. Evid Based Complement Altern Med vol. 2021, pp. 1–10, May 2021.
[7]
T.C. Silva Maiolini, W. Rosa, D. de Oliveira Miranda, et al. Essential Oils from Different Myrtaceae Species from Brazilian Atlantic Forest Biome – Chemical Dereplication and Evaluation of Antitrypanosomal Activity. Chem Biodivers vol. 19, no. 6, Jun. 2022
[8]
L.F.D. Passero, M.D. Laurenti, G. Santos-Gomes, et al. Plants Used in Traditional Medicine: Extracts and Secondary Metabolites Exhibiting Antileishmanial Activity. Curr Clin Pharmacol pp. 187–204, 2012.
[9]
E.J. Silva, A. Bezerra-Souza, L.F. Passero, et al. Synthesis, leishmanicidal activity, structural descriptors and structure-activity relationship of quinoline derivatives. Future Med Chem vol. 10, no. 17, pp. 2069–2085, Sep. 2018.
[10]
J.A. Jesus, I.M.O. Sousa, T.N.F. da Silva, et al. Preclinical Assessment of Ursolic Acid Loaded into Nanostructured Lipid Carriers in Experimental Visceral Leishmaniasis. Pharmaceutics vol. 13, no. 6, p. 908, Jun. 2021
[11]
A. Bezerra-Souza, J.A. Jesus, M.D. Laurenti, et al. Nanoemulsified Butenafine for Enhanced Performance against Experimental Cutaneous Leishmaniasis. J Immunol Res vol. 2021, pp. 1–13, Mar. 2021
[12]
Faustino and Pinheiro. Lipid Systems for the Delivery of Amphotericin B in Antifungal Therapy. Pharmaceutics vol. 12, no. 1, p. 29, Jan. 2020.
[13]
L.F.D. Passero, L.A. Cruz, G. Santos-Gomes, et al. Conventional versus natural alternative treatments for leishmaniasis :a review. Curr Top Med Chem Oct. 2018.

Rights & Permissions Print Cite
Article Metrics
14
1
© 2025 Bentham Science Publishers | Privacy Policy